Suchergebnisse - "Fibrinolytic Agents"

PubPharm (29)

1

Pharmacoeconomic review report : (Sanofi Genzyme, a division of Sanofi-Aventis Canada Inc.) : indication : indicated for the treatment of adults with acquired thrombotic thrombocytopenic purpura (aTTP) in combination with plasma exchange (PEX) and immunosuppressive therapyCaplacizumab (Cablivi)

Erschienen: [Ottawa], Canadian Agency for Drugs and Technologies in Health, October 2020

CADTH common drug review

Version: final (with redactions).

2

Consultative hemostasis and thrombosis

Erschienen: Philadelphia, PA, Elsevier, 2019

ClinicalKey

Fourth edition

von Konkle, B. | Kitchens, C. | Kessler, C. | +1

3

Thrombolytics for acute myocardial infarction in a prehospital setting : a review of comparative safety, and guidelines

Erschienen: Ottawa (ON), Canadian Agency for Drugs and Technologies in Health, July 9, 2019

CADTH rapid response report: summary with critical appraisal

Version 1.0.

von Marchand, D. | Farrah, K.

4

Comparing antithrombotic strategies after bioprosthetic aortic valve replacement : a systematic review

Erschienen: Washington, DC, Department of Veterans Affairs, Veterans Health Administration, Quality Enhancement Research Initiative, Health Services Research & Development Service, December 2017

Evidence-based synthesis program

von Papak, J.

5

Effect of thrombolytic treatment 3 to 4.5 hours after onset of stroke

Erschienen: Oslo, National Institute of Public Health, Division of Health Services, 2016

von Smedslund, G. | Myrhaug, H. | Hov, L. | +1

6

Atrial fibrillation : the management of atrial fibrillation

Erschienen: London, National Clinical Guideline Centre, June 2014

NICE clinical guidelines - No. 180

7

Ocriplasmin (Jetrea) (125 mcg intravitreal injection) : for the treatment of symptomatic vitreomacular adhesion

Erschienen: Ottawa (ON), Canadian Agency for Drugs and Technologies in Health, 2014

Common drug review clinical review report

8

Recommendations for antithrombotic agents for the prevention of stroke and systemic embolism in patients with atrial fibrillation

Erschienen: Ottawa (ON), Canadian Agency for Drugs and Technologies in Health, March 2013

CADTH therapeutic review recommendations

9

Antithrombotic agents for the prevention of stroke and systemic embolism in patients with atrial fibrillation

Erschienen: Ottawa (ON), Canadian Agency for Drugs and Technologies in Health, [2013]

CADTH therapeutic review - volume 1, issue 1B

10

Consultative hemostasis and thrombosis

Erschienen: Philadelphia, Pa, Elsevier/Saunders, c2013

Expertconsult

3rd ed

von Konkle, B. | Kitchens, C. | Kessler, C.